Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Passiglia

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2023
Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerDario P Anobile, Iris C Salaroglio, Fabrizio Tabbò, et al.
Critical Reviews in Oncology/Hematology|December 20, 2020
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second waveValentina Bertaglia, Maria Lucia Reale, Paolo Bironzo, et al.
Analytical Cellular Pathology (Amsterdam)|October 21, 2015
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Daniele Fanale, Giuseppe Bronte, Francesco Passiglia, et al.
Oncotarget|March 20, 2016
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR statusGiuseppe Bronte, Tindara Franchina, Massimiliano Alù, et al.
Critical Reviews in Oncology/Hematology|November 21, 2021
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patientsUmberto Malapelle, Sara Pilotto, Maria Lucia Reale, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2024
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based databaseUmberto Malapelle, Francesco Passiglia, Francesco Pepe, et al.
Lung Cancer (Amsterdam, Netherlands)|April 8, 2025
Current diagnostic and therapeutical approaches to bone metastases in patients with non-small cell lung cancer: A cross-sectional studyAlice Avancini, Niccolò Giaj-Levra, Gabriele Minuti, et al.
Cancer Treatment Reviews|November 22, 2025
Bone metastases in NSCLC: Modern paradigms in management and supportive careGabriele Minuti, Giorgia Pasqualini, Alice Avancini, et al.
Translational Lung Cancer Research|August 25, 2021
Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapyXuanye Zhang, Dan Tian, Yue Chen, et al.
Oncology|November 13, 2013
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variationsDaniele Fanale, Juan Lucio Iovanna, Ezequiel Luis Calvo, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2023
Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerDario P Anobile, Iris C Salaroglio, Fabrizio Tabbò, et al.
Critical Reviews in Oncology/Hematology|December 20, 2020
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second waveValentina Bertaglia, Maria Lucia Reale, Paolo Bironzo, et al.
Analytical Cellular Pathology (Amsterdam)|October 21, 2015
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Daniele Fanale, Giuseppe Bronte, Francesco Passiglia, et al.
Oncotarget|March 20, 2016
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR statusGiuseppe Bronte, Tindara Franchina, Massimiliano Alù, et al.
Critical Reviews in Oncology/Hematology|November 21, 2021
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patientsUmberto Malapelle, Sara Pilotto, Maria Lucia Reale, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2024
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based databaseUmberto Malapelle, Francesco Passiglia, Francesco Pepe, et al.
Lung Cancer (Amsterdam, Netherlands)|April 8, 2025
Current diagnostic and therapeutical approaches to bone metastases in patients with non-small cell lung cancer: A cross-sectional studyAlice Avancini, Niccolò Giaj-Levra, Gabriele Minuti, et al.
Cancer Treatment Reviews|November 22, 2025
Bone metastases in NSCLC: Modern paradigms in management and supportive careGabriele Minuti, Giorgia Pasqualini, Alice Avancini, et al.
Translational Lung Cancer Research|August 25, 2021
Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapyXuanye Zhang, Dan Tian, Yue Chen, et al.
Oncology|November 13, 2013
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variationsDaniele Fanale, Juan Lucio Iovanna, Ezequiel Luis Calvo, et al.
Pageof 13